Corient Private Wealth LLC lifted its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 24.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 26,225 shares of the company’s stock after purchasing an additional 5,224 shares during the period. Corient Private Wealth LLC’s holdings in BlackRock Health Sciences Term Trust were worth $378,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also modified their holdings of the company. Raymond James Financial Inc. acquired a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at approximately $10,869,000. Absolute Investment Advisers LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth $3,941,000. Wolverine Asset Management LLC increased its position in BlackRock Health Sciences Term Trust by 496.1% during the fourth quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock worth $2,702,000 after acquiring an additional 156,141 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in BlackRock Health Sciences Term Trust during the 4th quarter valued at $471,000. Finally, Kingswood Wealth Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at $420,000.
BlackRock Health Sciences Term Trust Stock Performance
NYSE BMEZ opened at $14.89 on Monday. The company’s fifty day moving average is $15.76 and its two-hundred day moving average is $15.58. BlackRock Health Sciences Term Trust has a 52-week low of $14.27 and a 52-week high of $16.75.
BlackRock Health Sciences Term Trust Dividend Announcement
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Do ETFs Pay Dividends? What You Need to Know
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- 3 Tickers Leading a Meme Stock Revival
- MarketBeat Week in Review – 03/24 – 03/28
- 3 REITs to Buy and Hold for the Long Term
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.